scispace - formally typeset
D

David S. Bredt

Researcher at Johnson & Johnson

Publications -  224
Citations -  63974

David S. Bredt is an academic researcher from Johnson & Johnson. The author has contributed to research in topics: Nitric oxide synthase & Nitric oxide. The author has an hindex of 107, co-authored 223 publications receiving 62332 citations. Previous affiliations of David S. Bredt include Johns Hopkins University & Georgetown University Medical Center.

Papers
More filters
Journal ArticleDOI

Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms

TL;DR: Stargazer, an ataxic and epileptic mutant mouse, lacks functional AMPA receptors on cerebellar granule cells, and expression of a mutant stargazin lacking the PDZ-binding domain in hippocampal pyramidal cells disrupts synaptic AMPA receptor receptors, indicating that st argazin-like mechanisms for targeting AM PA receptors may be widespread in the central nervous system.
Journal ArticleDOI

Nitric oxide in skeletal muscle

TL;DR: It is shown that rat skeletal muscle expresses neuronal-type NO synthase and that activity varies among several respiratory and limb muscles, and that two physiological functions of NO in skeletal muscle are supported.
Journal ArticleDOI

Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy.

TL;DR: In this paper, it was shown that dystrophin complex interacts with an N-terminal domain of nNOS that contains a GLGF motif, which may contribute to preferential degeneration of fast-twitch muscle fibers in Duchenne muscular dystrophy.
Journal ArticleDOI

Generation of superoxide by purified brain nitric oxide synthase.

TL;DR: Using a spin-trapping technique combined with electron spin resonance spectroscopy, it is reported that brain NOS generates superoxide O2-.
Journal ArticleDOI

Endogenous nitric oxide synthesis: Biological functions and pathophysiology

TL;DR: NO appears to play a major role in the pathophysiology of stroke, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis, and in the brain, NO functions as a neuromodulator and appears to mediate aspects of learning and memory.